{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:55:09Z","timestamp":1778864109908,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ejca.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,3,4]],"date-time":"2012-03-04T16:36:56Z","timestamp":1330879016000},"page":"1914-1921","source":"Crossref","is-referenced-by-count":65,"title":["High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion"],"prefix":"10.1016","volume":"48","author":[{"given":"Ha-Jeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Kyung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Gu","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chel Hun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Soo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Gie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2012.02.005_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2012.02.005_b0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3346\/jkms.2009.24.5.945","article-title":"Phase II study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer","volume":"24","author":"Kang","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ejca.2012.02.005_b0015","doi-asserted-by":"crossref","first-page":"20807","DOI":"10.1016\/S0021-9258(17)31891-4","article-title":"Galectins. Structure and function of a large family of animal lectins","volume":"269","author":"Barondes","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2012.02.005_b0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/glycob\/3.4.297","article-title":"The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution","volume":"3","author":"Hirabayashi","year":"1993","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejca.2012.02.005_b0025","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00018-007-7044-8","article-title":"Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival","volume":"64","author":"Elola","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ejca.2012.02.005_b0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1750-3639.2009.00270.x","article-title":"Galectins and gliomas","volume":"20","author":"Le Mercier","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ejca.2012.02.005_b0035","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Yang","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.ejca.2012.02.005_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrc1527","article-title":"Galectins as modulators of tumour progression","volume":"5","author":"Liu","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14712598.8.1.45","article-title":"Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer","volume":"8","author":"Salatino","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ejca.2012.02.005_b0050","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6602493","article-title":"Galectin-1 as a potential cancer target","volume":"92","author":"Rabinovich","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0055","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/(SICI)1097-4547(20000315)59:6<722::AID-JNR4>3.0.CO;2-H","article-title":"Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells","volume":"59","author":"Yamaoka","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ejca.2012.02.005_b0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jnen\/61.7.585","article-title":"Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases","volume":"61","author":"Camby","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.ejca.2012.02.005_b0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.LAB.0000059949.01480.40","article-title":"Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin","volume":"83","author":"van den Brule","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2012.02.005_b0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/B:GLYC.0000014085.00706.d4","article-title":"90K (Mac-2 BP) and galectins in tumor progression and metastasis","volume":"19","author":"Grassadonia","year":"2004","journal-title":"Glycoconj J"},{"key":"10.1016\/j.ejca.2012.02.005_b0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2567.1999.00746.x","article-title":"Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1","volume":"97","author":"Rabinovich","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.ejca.2012.02.005_b0080","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/378736a0","article-title":"Apoptosis of T cells mediated by galectin-1","volume":"378","author":"Perillo","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2012.02.005_b0085","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1158\/0008-5472.CAN-10-4157","article-title":"Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis","volume":"71","author":"Banh","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.02.005_b0090","doi-asserted-by":"crossref","first-page":"15975","DOI":"10.1073\/pnas.0603883103","article-title":"Galectin-1 is essential in tumor angiogenesis and is a target for anti angiogenesis therapy","volume":"103","author":"Thijssen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2012.02.005_b0095","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2007-03-077792","article-title":"Galectins in the tumor endothelium: opportunities for combined cancer therapy","volume":"110","author":"Thijssen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2012.02.005_b0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2353\/ajpath.2008.070938","article-title":"The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells","volume":"172","author":"Thijssen","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2012.02.005_b0105","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1158\/0008-5472.CAN-09-4150","article-title":"Tumor cells secrete galectin-1 to enhance endothelial cell activity","volume":"70","author":"Thijssen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.02.005_b0110","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/ijc.22434","article-title":"Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer","volume":"120","author":"Jung","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0115","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/onc.2009.70","article-title":"Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness","volume":"28","author":"Cimmino","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2012.02.005_b0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/1541-7786.MCR-08-0297","article-title":"Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons","volume":"7","author":"Wu","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ejca.2012.02.005_b0125","first-page":"59","article-title":"Adhesion\/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis\/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas","volume":"29","author":"Saussez","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2012.02.005_b0130","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hed.20559","article-title":"Galectins as modulators of tumor progression in head and neck squamous cell carcinomas","volume":"29","author":"Saussez","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2012.02.005_b0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH730>3.0.CO;2-2","article-title":"Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients","volume":"193","author":"van den Brule","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.02.005_b0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.oraloncology.2007.03.004","article-title":"Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma","volume":"44","author":"Chiang","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2012.02.005_b0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000087841","article-title":"Prognostic significance of endogenous adhesion\/growth-regulatory lectins in lung cancer","volume":"69","author":"Szoke","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2012.02.005_b0155","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/cncr.11268","article-title":"Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting","volume":"97","author":"Nagy","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<39::AID-IJC8>3.0.CO;2-E","article-title":"Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas","volume":"84","author":"Cindolo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/002215540104900414","article-title":"Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer","volume":"49","author":"Berberat","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ejca.2012.02.005_b0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3171\/JNS\/2008\/109\/8\/0273","article-title":"Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines","volume":"109","author":"Jung","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2012.02.005_b0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2119\/molmed.2009.00119","article-title":"Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness","volume":"16","author":"Spano","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.ejca.2012.02.005_b0180","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/MPA.0b013e318217945e","article-title":"Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma","volume":"40","author":"Xue","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.ejca.2012.02.005_b0185","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/1078-0432.CCR-10-1824","article-title":"Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1\/CCL2 expression","volume":"17","author":"Wu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2012.02.005_b0190","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cncr.10710","article-title":"Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy","volume":"95","author":"Branle","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.02.005_b0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/bc900287y","article-title":"Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene","volume":"21","author":"Dings","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ejca.2012.02.005_b0200","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/0264-6021:3540233","article-title":"Anginex, a designed peptide that inhibits angiogenesis","volume":"354","author":"Griffioen","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.ejca.2012.02.005_b0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0304-3835(03)00015-6","article-title":"Anti-tumor activity of the novel angiogenesis inhibitor anginex","volume":"194","author":"Dings","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2012.02.005_b0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canlet.2008.02.048","article-title":"Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven","volume":"265","author":"Dings","year":"2008","journal-title":"Cancer Lett"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T04:41:53Z","timestamp":1641012113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0959804912001426"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.02.005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}